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Abstract 
Infertility is one of the medical, social and psychological burdens in Iraqi society. Thyroid dysfunction can lead 
to menstrual disturbance, anovulatory cycle and decreased fertility. The study was designed to evaluate the role 
of thyroid disorders in infertility with emphasis on autoimmunity by Measuring T3, T4, TSH, & anti Thyroid 
peroxidase antibody in infertile females comparing the results with matching fertile controls. The study was 
conducted during the period from March 2015 to September 2015 at Karbala Maternity Hospital, infertility unit, 
and some private clinics. This study included a total number of 143 women in the reproductive age; ranging 
between (15- 43) years; divided into: The patients group included 92 infertile females; while controls were 
51fertile females. The following parameters were measured for all study groups: T3, T4, TSH, &anti-TPO using 
ELISA device. The results showed that there were 60.8% of patients with primary infertility (n =56) while 38.2% 
were with secondary infertility (n= 36). There was a significant difference in T3, and Anti-TPO between patients 
and controls being higher in patients; (p-value <0.05). In addition; Anti-TPO level was significantly higher in 
secondary infertile patients compared to primary infertile patients. In conclusion; Thyroid disorders are closely 
related to infertility in Iraqi females; and Anti-TPO may be used as a biochemical indicator of subclinical thyroid 
disorders and may help in assessment of thyroid function as a cause of infertility whether primary or secondary. 
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1. Introduction 
Infertility is defined as failure to achieve a clinical pregnancy or inability of a couple to conceive naturally after 
12 months or more of regular unprotected sexual intercourse (Gurunath et al 2011). It is classified into: 
1. Primary infertility: in women whose pregnancy spontaneously miscarries, or whose pregnancy results in a still 
born child, without ever having had a live birth (Zegers-Hochschild et al 2009) 
2. Secondary infertility: in those who repeatedly spontaneously miscarry or whose pregnancy results in a 
stillbirth following either a previous pregnancy or a previous ability to carry a pregnancy to a live birth 
(Cousineau et al 2007). 
There are many causes of female infertility; Endocrine disorders and hormonal disturbances represent 
important ones affecting female reproduction and ovulation (Masoumi et al 2015). 
Disorder of thyroid gland can cause infertility (Krassas et al 2010). Thyroid diseases are the most 
common endocrine disease in females at reproductive age. Thus, evaluation of thyroid functions during both 
pregnancy and treatment of infertility and treating relevant pathologies became important (Davis et al 2007, Van 
den Boogaard et al 2011). Autoimmune mechanisms are involved in the etiology of numerous thyroid diseases. 
The antibodies against thyroid tissues may exert negative effects on fertility due to immune dysfunction, cellular 
damage and decrease in thyroid hormones (Andreeva P. 2014). 
Autoimmune thyroid diseases are the most common autoimmune conditions encountered in females in 
reproductive age characterized by presence of antibodies against some structures of thyroid gland such as thyroid 
peroxsidase (TPO), thyroglobulin, and thyroid microsomes (Abalovich et al 2007). 
TPO is the key thyroid enzyme catalyzing both the iodination and coupling reaction for the synthesis of 
thyroid hormone (McLachlan et al 1992). Anti-TPO autoantibodies are present in approximately 90% of patients 
with autoimmune thyroid diseases and they are mainly of the IgG class (Silva et al 2003). Anti-TPO 
autoantibodies in pregnancy are markers for postpartum and long-term thyroid dysfunction (Premawardhana et 
al 2004). 
The aim of this study was to evaluate the role of thyroid disorders in infertility with emphasis on 
autoimmunity by Measuring T3, T4, TSH, & Anti-TPO autoantibodies in infertile Iraqi females. 
 
2. Material & Methods 
Study design: The study is case-control based study designed to determine thyroid disorders in infertile female. 
The study was conducted during the period from March 2015 to September 2015 at Karbala Maternity Hospital , 
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infertility unit, and some private clinics. 
The study consisted of a total number of 143 women in the reproductive age, the age range was between 
(15- 43) years. The patients were 92 infertile females and 51fertile females. Control samples were collected from 
the community and some of the staff in the hospital and the university. 
Diagnosis of infertility and patient selection were done by gynecologist present in infertility unit at 
Karbala Maternity Hospital. 
Blood samples were collected from all participants; sera were separated and frozen for measurement of 
T3, T4, TSH, & Anti-TPO using ELISA device in Imam Hussein Teaching Hospital. 
 
3. Results 
Among the 92 patients included in the study; 56 females were with primary infertility (60.8%) while 36 females 
were with secondary infertility (38.2%) (Figure 1). 
There was a significant difference between patients and control groups in levels of T3 and Anti-TPO; 
being higher in patients. Whereas there was no significant difference in both T4 and TSH between the two 
aforementioned groups (table 1). 
The study also showed a significantly higher levels of Anti-TPO in secondary infertile patients 
compared to primary infertile females, no significant differences were found in T3, T4, or TSH levels ; 
respectively. (Table 2). 
 
4. Discussion 
Infertility is one of the medical, social and psychological burdens in Iraqi society (Frayyehl et al 2014). Most of 
patients in this study were with primary infertility; this agrees with previous studies (Al-Turki 2015, 
Kazemijaliseh et al 2015). Most newly married couples seek pregnancy and attend health services more 
frequently than those who already have a child. Moreover; Iraqi families take primary infertility much more 
seriously than secondary infertility. 
Thyroid dysfunction can lead to menstrual disturbance, an ovulatory cycle, and decreased fertility (Rijal 
et al 2011). In women of reproductive age, the most prevalent cause of thyroid dysfunction is thyroid 
autoimmunity (Basal and Hayman et al 2009). 
Results of the present study showed that serum Triiodothyronine T3 was significantly higher in 
infertility patients compared with control group, while no significant difference was found in total thyroxin; our 
results are consistent with a previous study done by (Omar et al 2015). Regarding the relation between T3, T4 
levels and the type of infertility (primary or secondary), the result revealed no significant difference and this is 
consistent with (Maysaloun et al 2012). This could be explained by the variable expression of thyroid hormone 
receptors in female reproductive system as stated by López et al (2015) who found that thyroid hormone 
receptors were differently expressed in granulosa and cervical cells of infertile females and concluded that the 
expression of different markers of intracellular thyroid function is linked to fertility status. Resistance of these 
receptors will cause a reciprocal increase of the active thyroid hormone T3. 
Results showed that the serum TSH level was neither significantly different in infertile patients group 
compared with control group, nor in primary compared to secondary groups; which agrees with other studies 
(Sharma et al 2013, Bhavna et al 2013). TSH significantly up regulates growth factors expression in endometrial 
cell cultures, suggesting a potential role of TSH in the implantation process (Aghajanova et al 2011). Some 
researchers also emphasized on the relation between levels of TSH and hyperprolactenemia in causing infertility 
status (Shapla et al 2014). Nevertheless, TSH levels were a little bit higher in patients group compared to control; 
suggesting a state of subclinical thyroid disease, known as Sub-Clinical hypothyroidism; which is defined as an 
increase in serum TSH concentrations with normal free thyroxine levels. The prevalence of Sub-Clinical 
hypothyroidism in infertile women has been reported to vary from 0.7% to 43% .The wide range of prevalence is 
due to the differences in sensitivity of serum TSH measurement. (Poppe et al 2007) 
Our results show significantly higher Anti-TPO levels in serum of infertility group compared to that of 
control group, this agrees with (Maha et al 2014). Thyroid autoantibodies that react with key proteins in the 
thyroid, such as thyroid peroxidase can induce a chronic lymphocytic thyroiditis that ultimately results in 
destruction and loss of thyroid function; ultimately affecting fertility. Regarding the type or cause of infertility, 
data of the current study found that there is a significant difference in serum levels of Anti-TPO between primary 
and secondary infertility. These results might be explained by age variation between women with primary and 
secondary infertility. Nevertheless, there is a paucity of researches in this field. 
 
5. Conclusion 
Thyroid disorders are closely related to subfertility and infertility in Iraqi females especially autoimmune thyroid 
diseases. Also Anti-TPO may be used as a biochemical indicator of subclinical thyroid disorders and may help in 
assessment of thyroid function as a cause of infertility whether primary or secondary.   
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Table 1: Serum levels of TPO, TSH ,T3 and T4 in patients and control groups   
Parameters Group                Mean ±  SEM      Range   p- Value 
      TPO            
IU/ml        
Patient     60.59± 13.42  0.001- 840  
<0.05  Control      29.33 ± 2.776 0.002-78 
    TSH 
     mIu/l       
Patient       2.466 ± 0.2069  0.004-11.8          
 >0.05 Control      2.445± 0.2753 0.02-8.870  
   T3       
     ng/ml        
Patient        1.909± 0.0489  0.65-2.683  
<0.05    Control        1.629± 0.0524     0.63- 2.040 
        T4      
      ng/ml      
Patient    8.863± 0.364 0.105-22.99   
>0.05     Control    8.690± 0.3482         3.49- 13.42 
 TPO=Anti-thyroid peroxidase , TSH=thyrotropine ,T3= Triiodothyronine , T4=thyroxin 
SEM=Stander error mean , IU =international unite ,ml =milliliter , ng =Nano gram 
   
Table 2: Serum levels of TPO, TSH ,T3 and T4 in primary and secondary infertile females  
Parameters Type of Group   Mean ±  SEM      Range p-value       
        TPO    
     IU/ml      
Primary 50.99± 13.37  0.001-548.2  
   <0.05    Secondary      75.54± 27.39  0.264-840.7 
      TSH 
       mIU/ml    
Primary   2.250 ± 0.2097  0.004-8.801  
  >0.05    Secondary      2.801± 0.4141  0.02-11.8 
     T3     
       ng/ml        
Primary 1.862± 0.0689  0.6500-2.683  
   >0.05      Secondary      1.983± 0.0636  0.870-2.649 
    T4   
    ng/ml        
Primary 8.871 ± 0.4933   0.105- 22.99  
  >0.05      Secondary      8.850± 0.5385   1.665- 20.11 
TPO=thyroid peroxidase, TSH=thyrotropine, T3= Triiodothyronine, T4=thyroxin 
SEM=Stander error mean, IU =international unite, ml =milliliter, ng =Nano gram    
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Figure 1. Type of infertility in patients' group 
 
 
 
 
 
